We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$43.3B
1-Year Est. Return
29.3%
This Fund
S&P 500
This Quarter
Est. Return
+17.09%
1 Year Est. Return
+29.3%
3 Year Est. Return
+83.12%
5 Year Est. Return
+90.93%
10 Year Est. Return
+282.52%
AUM
$43.3B
AUM Growth
+$4.47B
(+12%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-0.28%
Top 10 Holdings %
Top 10 Hldgs %
19.72%
Holding
4,210
New
286
Increased
1,913
Reduced
1,499
Closed
436
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$126M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$78.7M |
| 3 |
Invesco NASDAQ 100 ETF
QQQM
|
+$69.1M |
| 4 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$63.9M |
| 5 |
Putnam Focused Large Cap Value ETF
PVAL
|
+$51.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FT Vest Fund of Buffer ETFs
BUFR
|
+$111M |
| 2 |
Netflix
NFLX
|
+$80.4M |
| 3 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$73.5M |
| 4 |
Invesco Ultra Short Duration ETF
GSY
|
+$67.5M |
| 5 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$63.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.13% |
| 2 | Financials | 4.34% |
| 3 | Industrials | 3.63% |
| 4 | Consumer Discretionary | 3.11% |
| 5 | Communication Services | 2.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3676
Invesco Mortgage Capital
IVR
$769M
| $88K | ﹤0.01% |
+11,168
| New | +$90K |
|
3677
NeuroOne Medical Technologies
NMTC
$14.5M
| $87K | ﹤0.01% |
28,499
-1
| -0% | -$4 |
|
|
RENT
3678
Rent the Runway
RENT
$119M
| $87K | ﹤0.01% |
27,597
-5,368
| -16% | -$22.7K |
|
|
WIW
3679
Western Asset Inflation-Linked Opportunities & Income Fund
WIW
$507M
| $86K | ﹤0.01% |
+10,201
| New | +$86.6K |
|
|
PNNT
3680
Pennant Park Investment Corp
PNNT
$221M
| $84K | ﹤0.01% |
24,349
-1,630
| -6% | -$6.76K |
|
3681
Goodyear
GT
$2.12B
| $81K | ﹤0.01% |
12,239
-11,590
| -49% | -$74.6K |
|
3682
Riverview Bancorp
RVSB
$109M
| $81K | ﹤0.01% |
14,876
| – | – |
|
3683
Sana Biotechnology
SANA
$916M
| $79K | ﹤0.01% |
22,594
+3,000
| +15% | +$9.66K |
|
3684
Champions Oncology
CSBR
$76.8M
| $75K | ﹤0.01% |
12,252
| – | – |
|
3685
Hyliion Holdings
HYLN
$631M
| $75K | ﹤0.01% |
14,451
+830
| +6% | +$3.45K |
|
3686
BRC Inc
BRCC
$118M
| $73K | ﹤0.01% |
66,036
-870
| -1% | -$1.08K |
|
3687
Coherus Oncology
CHRS
$222M
| $73K | ﹤0.01% |
52,376
+8,800
| +20% | +$14.4K |
|
|
ELWT
3688
Elauwit Connection Inc
ELWT
$54.7M
| $72K | ﹤0.01% |
10,000
| – | – |
|
3689
Nordic American Tanker
NAT
$1.35B
| $71K | ﹤0.01% |
12,825
-2,166
| -14% | -$12.3K |
|
|
CRON
3690
Cronos Group
CRON
$1.06B
| $70K | ﹤0.01% |
25,318
-513
| -2% | -$1.38K |
|
|
ONL
3691
Orion Office REIT
ONL
$148M
| $70K | ﹤0.01% |
24,346
-1,354
| -5% | -$3.71K |
|
3692
Acco Brands
ACCO
$401M
| $69K | ﹤0.01% |
16,643
| – | – |
|
|
NHS
3693
Neuberger High Yield Strategies Fund Inc
NHS
$251M
| $69K | ﹤0.01% |
11,031
+436
| +4% | +$2.78K |
|
3694
Evolv Technologies
EVLV
$1.01B
| $68K | ﹤0.01% |
+11,701
| New | +$73.3K |
|
3695
Vuzix
VUZI
$187M
| $67K | ﹤0.01% |
23,083
-178
| -0.8% | -$561 |
|
|
DPRO
3696
Draganfly
DPRO
$151M
| $66K | ﹤0.01% |
12,224
+174
| +1% | +$1.01K |
|
3697
Rekor Systems
REKR
$86.9M
| $64K | ﹤0.01% |
92,015
+2,080
| +2% | +$1.63K |
|
|
ABTC
3698
American Bitcoin Corp
ABTC
$400M
| $64K | ﹤0.01% |
6,284
-2,858
| -31% | -$43.7K |
|
3699
Dominari Holdings
DOMH
$54.5M
| $63K | ﹤0.01% |
20,175
| – | – |
|
3700
Ardelyx
ARDX
$1.25B
| $62K | ﹤0.01% |
12,146
+1,000
| +9% | +$6.1K |
|
Similar funds
AS
DB
Cambridge Investment Research Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Cambridge Investment Research Advisors held 4,210 positions worth $43.3B, up 12% from $38.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Cambridge Investment Research Advisors's Q2 2026 filing shows 286 new, 1,913 increased, 1,499 reduced and 436 closed positions. Its largest new stake was SpaceX: 259,405 shares worth $44.3M. The largest sale was FT Vest Fund of Buffer ETFs, an estimated $111M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
- Cambridge Investment Research Advisors's largest Q2 2026 buy was SpaceX: 259,405 shares worth $44.3M.
- Cambridge Investment Research Advisors added most to State Street SPDR Portfolio S&P 500 ETF in Q2 2026, an estimated $126M increase.
- Cambridge Investment Research Advisors's biggest Q2 2026 reduction was JPMorgan Ultra-Short Income ETF, cutting an estimated $73.5M.
- Cambridge Investment Research Advisors fully exited FT Vest Fund of Buffer ETFs in Q2 2026, selling an estimated $111M.
- Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $43.3B portfolio in Q2 2026.
- Cambridge Investment Research Advisors opened 286 new positions and closed 436 in Q2 2026.
- Cambridge Investment Research Advisors's portfolio value rose 12% quarter-over-quarter to $43.3B.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.